Eton Pharmaceuticals Stock Forecast, Price & News

Eton Pharmaceuticals (NASDAQ:ETON) Frequently Asked Questions

Is Eton Pharmaceuticals a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eton Pharmaceuticals in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Eton Pharmaceuticals stock.
View analyst ratings for Eton Pharmaceuticals or view top-rated stocks.

How has Eton Pharmaceuticals' stock been impacted by Coronavirus?

Eton Pharmaceuticals' stock was trading at $4.20 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ETON stock has decreased by 16.0% and is now trading at $3.53.
View which stocks have been most impacted by COVID-19.

When is Eton Pharmaceuticals' next earnings date?

Eton Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, March 15th 2022.
View our earnings forecast for Eton Pharmaceuticals.

How were Eton Pharmaceuticals' earnings last quarter?

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) announced its quarterly earnings results on Monday, November, 15th. The company reported ($0.24) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.14) by $0.10. The business earned $0.78 million during the quarter, compared to the consensus estimate of $3.05 million. Eton Pharmaceuticals had a negative trailing twelve-month return on equity of 58.04% and a negative net margin of 67.52%. During the same quarter in the prior year, the business earned ($0.31) EPS.
View Eton Pharmaceuticals' earnings history.

What price target have analysts set for ETON?

2 brokers have issued twelve-month price objectives for Eton Pharmaceuticals' stock. Their forecasts range from $11.00 to $14.00. On average, they expect Eton Pharmaceuticals' stock price to reach $12.50 in the next twelve months. This suggests a possible upside of 254.1% from the stock's current price.
View analysts' price targets for Eton Pharmaceuticals or view top-rated stocks among Wall Street analysts.

Who are Eton Pharmaceuticals' key executives?

Eton Pharmaceuticals' management team includes the following people:

• Sean E. Brynjelsen, President, Chief Executive Officer & Director (LinkedIn Profile)
• Wilson W. Troutman, Chief Financial Officer, Secretary & Treasurer
• Scott Grossenbach, Vice President-Sales & Marketing
• Ingrid Hoos, Senior Vice President-Scientific Affairs
• Paul Stickler, Senior Vice President-Sales & Marketing

Who are some of Eton Pharmaceuticals' key competitors?

Some companies that are related to Eton Pharmaceuticals include Nkarta (NKTX), Khosla Ventures Acquisition (KVSA), Oramed Pharmaceuticals (ORMP), Applied Molecular Transport (AMTI), Geron (GERN), BioDelivery Sciences International (BDSI), Omeros (OMER), Avadel Pharmaceuticals (AVDL), Adagene (ADAG), Vaccitech (VACC), AC Immune (ACIU), Immuneering (IMRX), Nanobiotix (NBTX), Pyxis Oncology (PYXS) and XBiotech (XBIT).
View all of ETON's competitors.

What other stocks do shareholders of Eton Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eton Pharmaceuticals investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Amarin (AMRN), Myovant Sciences (MYOV), Dynavax Technologies (DVAX), Inovio Pharmaceuticals (INO), Vaxart (VXRT), CymaBay Therapeutics (CBAY), Fulcrum Therapeutics (FULC) and Moderna (MRNA).

When did Eton Pharmaceuticals IPO?

(ETON) raised $22 million in an IPO on Wednesday, November 14th 2018. The company issued 3,600,000 shares at a price of $6.00 per share. National Securities Corporation served as the underwriter for the IPO.

What is Eton Pharmaceuticals' stock symbol?

Eton Pharmaceuticals trades on the NASDAQ under the ticker symbol "ETON."

How do I buy shares of Eton Pharmaceuticals?

Shares of ETON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eton Pharmaceuticals' stock price today?

One share of ETON stock can currently be purchased for approximately $3.53.

How much money does Eton Pharmaceuticals make?

Eton Pharmaceuticals has a market capitalization of $86.86 million and generates $40 thousand in revenue each year. The company earns $-27.97 million in net income (profit) each year or ($0.45) on an earnings per share basis.

How many employees does Eton Pharmaceuticals have?

Eton Pharmaceuticals employs 16 workers across the globe.

What is Eton Pharmaceuticals' official website?

The official website for Eton Pharmaceuticals is www.etonpharma.com.

Where are Eton Pharmaceuticals' headquarters?

Eton Pharmaceuticals is headquartered at 21925 W. FIELD PARKWAY SUITE 235, DEER PARK IL, 60010.

How can I contact Eton Pharmaceuticals?

Eton Pharmaceuticals' mailing address is 21925 W. FIELD PARKWAY SUITE 235, DEER PARK IL, 60010. The company can be reached via phone at (847) 787-7361 or via email at [email protected].